Patents Assigned to NANOCARE TECHNOLOGIES, INC.
  • Publication number: 20200164074
    Abstract: The disclosure describes jasmonate conjugates and nanocarried and/or microcarried jasmonate conjugates and pharmaceutical compositions thereof, as well as use thereof for treating or preventing angiogenesis-related or NF-?B-related disorders. Also disclosed are methods of making the conjugates.
    Type: Application
    Filed: April 24, 2019
    Publication date: May 28, 2020
    Applicant: Nanocare Technologies, Inc.
    Inventor: Jose E. Fehr Pereira LOPES
  • Patent number: 10328155
    Abstract: The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-?B-related disorders. Also disclosed are methods of making the nanocarried and/or microcarried compounds and their compositions.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: June 25, 2019
    Assignee: NANOCARE TECHNOLOGIES, INC.
    Inventor: Jose E. Fehr Pereira Lopes
  • Patent number: 10314918
    Abstract: The disclosure describes jasmonate conjugates and nanocarried and/or microcarried jasmonate conjugates and pharmaceutical compositions thereof, as well as use thereof for treating or preventing angiogenesis-related or NF-?B-related disorders. Also disclosed are methods of making the conjugates.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: June 11, 2019
    Assignee: NANOCARE TECHNOLOGIES, INC.
    Inventor: José E. Fehr Pereira Lopes
  • Patent number: 9592305
    Abstract: The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-?B-related disorders. Also disclosed are methods of making the nanocarried and/or microcarried compounds and their compositions.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: March 14, 2017
    Assignee: Nanocare Technologies, Inc.
    Inventor: José E. Fehr Pereira Lopes
  • Patent number: 8883220
    Abstract: The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-?B-related disorders. Also disclosed are methods of making the nanocarried and/or microcarried compounds and their compositions.
    Type: Grant
    Filed: September 17, 2012
    Date of Patent: November 11, 2014
    Assignee: NanoCare Technologies, Inc.
    Inventor: José E. Fehr Pereira Lopes
  • Publication number: 20130089615
    Abstract: The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-?B-related disorders. Also disclosed are methods of making the nanocarried and/or microcarried compounds and their compositions.
    Type: Application
    Filed: September 17, 2012
    Publication date: April 11, 2013
    Applicant: NANOCARE TECHNOLOGIES, INC.
    Inventor: NanoCare Technologies, Inc.